seermedicare.docxoutins.com/wp-content/uploads/2016/03/seermedicar… · web view2016/01/18 ·...
TRANSCRIPT
Overview of All SEER-Medicare Publications
Outcomes Insights, Inc.
Mark D. Danese, MHS, PhDClaire Cangialose
March 23, 2016
Overview
● Information was extracted from the National Cancer Institute (NCI) online reference database for "SEER-Medicare" publications
○ http://healthcaredelivery.cancer.gov/seermedicare/overview/pubsearch.html ○ Data accessed January 18, 2016 - articles published in 2015 and 2016 may be
underrepresented due to reporting lag○ 1363 citations retrieved○ NCI classified all publications according to the following:
● 19 tumor types (e.g., colorectal, leukemia, etc.)● 28 topic areas (e.g., outcomes (all), health disparities, etc.)
● Summary measures were calculated by year, tumor site, topic area, journal, and author● Exploratory analyses were conducted to assess publication frequency relative to cancer incidence,
prevalence, and deaths● All analyses were conducted using R version 3.2.3 (2015-12-10)● All data were extracted from internet-based sources on January 18, 2016 using the rvest package
(version 0.3.1)● Figures were created using the ggplot2 package (version 2.1.0)● This report was generated using the ReporteRs package (version 0.8.6)
SEER-Medicare Publications Search
Tumor Sites:1. Breast2. Prostate3. Colorectal4. Lung5. All Sites or No Specific Site6. Other7. Urinary Bladder8. Head and Neck9. Pancreas10. Ovary11. Renal12. Lymphoma13. Liver14. Esophagus15. Corpus Uteri16. Leukemia17. Gastric18. Brain & Other Nervous System19. Cervical
Topic Areas:1. Outcomes (All)2. Treatment3. Palliative & End-of-Life Care4. Health Care Systems5. Health Disparities6. Economics of Cancer7. Economics of Cancer - Health Care
Costs8. Risk Factors9. Research Methodology10. None11. Survivorship12. Economics of Cancer - Cost of
Illness13. Screening14. Clinical Outcomes15. Prevention16. Surveillance17. Preventive & Screening Services18. Quality of Care19. Tobacco20. Health Behaviors & Survivorship21. Policy22. Methods for Assessing Risk
Factors23. Epidemiologic, Experimental, &
Methodological Studies24. Epidemiology Studies & Related
Methods25. Guidance & Policy Research26. Decision-Making27. Health-Related Quality of Life28. Outcomes Research Measures &
Methods
Summary of Publications
Exploratory Analyses: Publications Relative to Population Size
Methodology● Publication counts were plotted against tumor types● Counts of incident and prevalent patients, as well as deaths from cancer, were taken from SEER
published estimates● Ratios of publications to these patient counts were estimated
○ Publications divided by incidence (1,000 patients)○ Publications divided by prevalence (10,000 patients)○ Publications divided by deaths (1,000 deaths)○ Higher numbers reflect more publications per patient○ The median publication ratio across all tumors was used as an index for establishing high
versus low ratios
Publications per patient according to incidence, prevalence, and death
Bre
ast
Pros
tate
Col
orec
tal
Lung
Urin
ary
Bla
dder
Hea
d an
d N
eck
Panc
reas
Ova
ry
Ren
al
Lym
phom
a
Live
r
Esop
hagu
s
Cor
pus U
teri
Leuk
emia
Gas
tric
Bra
in &
Oth
er N
ervo
us S
yste
m
Cer
vica
l
Total Publication
s
318 314 299 188 60 59 53 50 50 42 33 28 21 19 18 11 9
% incide
nt patients 65 years
or older (2008
-2012)
43% 57% 60% 68% 73% 42% 66% 47% 49% 52% 46% 58% 42% 55% 61% 37% 20%
Pub/Incide
nce ratio per
1,000 (2015
)
1.4 1.4 2.3 0.8 0.8 1.3 1.1 2.3 0.8 0.5 0.9 1.6 0.4 0.4 0.7 0.5 0.7
Pub/Prevalence
1.1 1.1 2.6 4.6 1.0 2.0 11.6 2.6 1.3 0.6 6.5 7.8 0.3 0.6 2.3 0.7 0.4
Publications per patient according to incidence, prevalence, and death
Bre
ast
Pros
tate
Col
orec
tal
Lung
Urin
ary
Bla
dder
Hea
d an
d N
eck
Panc
reas
Ova
ry
Ren
al
Lym
phom
a
Live
r
Esop
hagu
s
Cor
pus U
teri
Leuk
emia
Gas
tric
Bra
in &
Oth
er N
ervo
us S
yste
m
Cer
vica
l
ratio per
10,000
(2012)
Pub/Deaths ratio
per 1,000 (2015
)
7.9 11.4 6.0 1.2 3.8 6.8 1.3 3.5 3.6 2.0 1.3 1.8 2.1 0.8 1.7 0.7 2.2
Notes: Higher numbers indicate more publications per patient (see table for comparisons to the median ratios)
Publications per patient according to incidence, prevalence, and death, standardized to the median ratio
Bre
ast
Pros
tate
Col
orec
tal
Lung
Urin
ary
Bla
dder
Hea
d an
d N
eck
Panc
reas
Ova
ry
Ren
al
Lym
phom
a
Live
r
Esop
hagu
s
Cor
pus U
teri
Leuk
emia
Gas
tric
Bra
in &
Oth
er N
ervo
us S
yste
m
Cer
vica
l
Total Publication
s
318 314 299 188 60 59 53 50 50 42 33 28 21 19 18 11 9
% incide
nt patients 65 years
or older (2008
-2012)
43% 57% 60% 68% 73% 42% 66% 47% 49% 52% 46% 58% 42% 55% 61% 37% 20%
Pub/Incide
nce ratio per
1,000 (2015
)
1.6 1.7 2.7 1.0 1.0 1.5 1.3 2.8 1.0 0.6 1.1 1.9 0.5 0.4 0.9 0.6 0.8
Pub/Prevalence
0.8 0.8 1.9 3.5 0.8 1.5 8.7 2.0 1.0 0.4 4.9 5.9 0.3 0.4 1.8 0.6 0.3
Publications per patient according to incidence, prevalence, and death, standardized to the median ratio
Bre
ast
Pros
tate
Col
orec
tal
Lung
Urin
ary
Bla
dder
Hea
d an
d N
eck
Panc
reas
Ova
ry
Ren
al
Lym
phom
a
Live
r
Esop
hagu
s
Cor
pus U
teri
Leuk
emia
Gas
tric
Bra
in &
Oth
er N
ervo
us S
yste
m
Cer
vica
l
ratio per
10,000
(2012)
Pub/Deaths ratio
per 1,000 (2015
)
3.8 5.5 2.9 0.6 1.8 3.3 0.6 1.7 1.7 1.0 0.7 0.9 1.0 0.4 0.8 0.3 1.1
Notes: Ratios reflect the tumor-specific publication ratio relative to median publication ratio (see table for non-standardized ratios) - values above 1.0 indicate ratios higher than the median, and values below 1.0 indicate ratios below the median (shaded orange)
Conclusions
● There has been steady growth in the number of publications over time using the SEER-Medicare data
● Breast, prostate, colorectal, and lung are the tumor sites with the highest number of publications○ This corresponds well with estimates of incidence and prevalence in the United States
population● The number of publications appears to align better with incidence and prevalence than with death,
particularly for more common cancers● Leukemia, lymphoma, lung, and renal might be under-represented in terms of the absolute number
of publications
Data Sources
● Incidence (2015), Prevalence (2012), and Deaths (2015)○ Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu
M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2012, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2012/, based on November 2014 SEER data submission, posted to the SEER web site, April 2015.
● Proportion of patients age 65 or older at diagnosis (2008-2012)○ U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2012
Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2015. Available at: www.cdc.gov/uscs.
● All Site and Morphology classifications were aligned among all data sources with a few exceptions:
○ Head and Neck was defined using SEER/CDC category: Oral Cavity and Pharynx○ Corpus Uteri was defined using SEER/CDC category: Endometrial Cancer
Acknowledgements
Thanks to Marc Halperin and Ryan Duryea who helped to automate this and previous versions of this report
Contact Information
Mark D. DaneseOutcomes Insights, Inc.2801 Townsgate Road, Suite #330Westlake Village, CA [email protected]